BACKGROUND AND PURPOSE: Ischemic stroke is commonly embolic, either from carotid atherosclerosis or from cardiac origin. These potential sources of emboli need to be investigated to accurately prescribe secondary stroke prevention. Moreover, the mortality in ischemic stroke patients due to ischemic heart disease is greater than that of age-matched controls, thus making evaluation for coronary artery disease important in this patient population. The purpose of this study was to evaluate the image quality of a comprehensive CTA protocol in patients with acute stroke that expands the standard CTA coverage to include all 4 chambers of the heart and the coronary arteries. MATERIALS AND METHODS: One hundred twenty patients consecutively admitted to the emergency department with suspected cerebrovascular ischemia undergoing standard-of-care CTA were prospectively enrolled in our study. We used an original tailored acquisition protocol using a 64-section CT scanner, consisting of a dual-phase intravenous injection of iodinated contrast and saline flush, in conjunction with a dual-phase CT acquisition, ascending from the top of the aortic arch to the vertex of the head, then descending from the top of the aortic arch to the diaphragm. No beta blockers were administered. The image quality, attenuation, and CNRs of the carotid, aortic, vertebral, and coronary arteries were assessed. RESULTS: Carotid, aorta, and vertebral artery image quality was 100% diagnostic (rated good or excellent) in all patients. Coronary artery image quality was diagnostic in 58% of RCA segments, 73% of LAD segments, and 63% of LCX segments. When we considered proximal segments only, the diagnostic quality rose to 71% in the RCA, 83% in the LAD, and 74% in the LCX. CONCLUSIONS: Our stroke protocol achieved excellent opacification of the left heart chambers, the cervical arteries, and each coronary artery, in addition to adequate carotid and coronary artery image quality.
BACKGROUND AND PURPOSE:Ischemic stroke is commonly embolic, either from carotid atherosclerosis or from cardiac origin. These potential sources of emboli need to be investigated to accurately prescribe secondary stroke prevention. Moreover, the mortality in ischemic strokepatients due to ischemic heart disease is greater than that of age-matched controls, thus making evaluation for coronary artery disease important in this patient population. The purpose of this study was to evaluate the image quality of a comprehensive CTA protocol in patients with acute stroke that expands the standard CTA coverage to include all 4 chambers of the heart and the coronary arteries. MATERIALS AND METHODS: One hundred twenty patients consecutively admitted to the emergency department with suspected cerebrovascular ischemia undergoing standard-of-care CTA were prospectively enrolled in our study. We used an original tailored acquisition protocol using a 64-section CT scanner, consisting of a dual-phase intravenous injection of iodinated contrast and salineflush, in conjunction with a dual-phase CT acquisition, ascending from the top of the aortic arch to the vertex of the head, then descending from the top of the aortic arch to the diaphragm. No beta blockers were administered. The image quality, attenuation, and CNRs of the carotid, aortic, vertebral, and coronary arteries were assessed. RESULTS: Carotid, aorta, and vertebral artery image quality was 100% diagnostic (rated good or excellent) in all patients. Coronary artery image quality was diagnostic in 58% of RCA segments, 73% of LAD segments, and 63% of LCX segments. When we considered proximal segments only, the diagnostic quality rose to 71% in the RCA, 83% in the LAD, and 74% in the LCX. CONCLUSIONS: Our stroke protocol achieved excellent opacification of the left heart chambers, the cervical arteries, and each coronary artery, in addition to adequate carotid and coronary artery image quality.
Authors: Bernd J Wintersperger; Konstantin Nikolaou; Franz von Ziegler; Thorsten Johnson; Carsten Rist; Alexander Leber; Thomas Flohr; Andreas Knez; Maximilian F Reiser; Christoph R Becker Journal: Invest Radiol Date: 2006-05 Impact factor: 6.016
Authors: Sebastiaan F T M de Bruijn; Willem R P Agema; Gert Jan Lammers; Ernst E van der Wall; Ron Wolterbeek; Eduard R Holman; Edward L E M Bollen; Jeroen J Bax Journal: Stroke Date: 2006-08-31 Impact factor: 7.914
Authors: B R Chaitman; K B Davis; G C Kaiser; G Mudd; R D Wiens; G S Ng; E R Passamani; T Killip Journal: Circulation Date: 1986-11 Impact factor: 29.690
Authors: B R Chaitman; L D Fisher; M G Bourassa; K Davis; W J Rogers; C Maynard; D H Tyras; R L Berger; M P Judkins; I Ringqvist; M B Mock; T Killip Journal: Am J Cardiol Date: 1981-10 Impact factor: 2.778
Authors: M Trelles; K M Eberhardt; M Buchholz; A Schindler; A Bayer-Karpinska; M Dichgans; M F Reiser; K Nikolaou; T Saam Journal: AJNR Am J Neuroradiol Date: 2013-07-18 Impact factor: 3.825
Authors: Guo Zhong Chen; Long Jiang Zhang; U Joseph Schoepf; Julian L Wichmann; Cole M Milliken; Chang Sheng Zhou; Li Qi; Song Luo; Guang Ming Lu Journal: Eur Radiol Date: 2015-01-31 Impact factor: 5.315
Authors: Song Luo; Long Jiang Zhang; Felix G Meinel; Chang Sheng Zhou; Li Qi; Andrew D McQuiston; U Joseph Schoepf; Guang Ming Lu Journal: Eur Radiol Date: 2014-05-04 Impact factor: 5.315
Authors: Q Q Ni; G Z Chen; U J Schoepf; M A J Klitsie; C N De Cecco; C S Zhou; S Luo; G M Lu; L J Zhang Journal: AJNR Am J Neuroradiol Date: 2016-05-05 Impact factor: 3.825
Authors: Tess Reynolds; Yiqun Q Ma; Andrew J Kanawati; Alex Constantinidis; Zoe Williams; Grace Gang; Owen Dillon; Tom Russ; Wenying Wang; Tina Ehtiati; Clifford R Weiss; Nicholas Theodore; Jeffery H Siewerdsen; Joseph W Stayman; Ricky T O'Brien Journal: Invest Radiol Date: 2022-05-03 Impact factor: 10.065